LSV Asset Management Sells 15,200 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

LSV Asset Management lowered its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 30.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,300 shares of the company’s stock after selling 15,200 shares during the period. LSV Asset Management’s holdings in Pediatrix Medical Group were worth $450,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pacer Advisors Inc. bought a new position in shares of Pediatrix Medical Group in the 4th quarter valued at about $35,492,000. American Century Companies Inc. boosted its position in Pediatrix Medical Group by 628.2% during the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after purchasing an additional 1,500,485 shares during the last quarter. Renaissance Technologies LLC grew its stake in Pediatrix Medical Group by 117.4% in the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock valued at $11,005,000 after purchasing an additional 453,000 shares in the last quarter. Boston Partners increased its position in shares of Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock worth $25,922,000 after purchasing an additional 393,600 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $3,066,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Truist Financial lowered their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a report on Friday. Macquarie assumed coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. UBS Group lifted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $16.75.

Pediatrix Medical Group Trading Up 0.6 %

Shares of MD stock opened at $13.42 on Tuesday. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67. The company has a market capitalization of $1.15 billion, a PE ratio of -11.18, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. The firm has a 50 day moving average price of $14.32 and a two-hundred day moving average price of $13.95. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.